Mitchell works with samples collected by a local biotechnical company that develops bowel bioperapy. Its probiotic products used to treat repetition C. Razl Infections contain eight closely related microbial strains belonging to the order known as Clostridiales. The company gave one of its products to 56 human subjects and collected the samples of the chair over time. Mitchell uses the techniques of genetic sequencing for monitoring that three types of microbial species have developed in 21 subjects. Recognizing the various differences and similarities can be detected in the host environment and could help you explain why some kind of mutations allow some microbes to survive and progress. The project is still in the early stages, but Mitchell has a work hypothesis.
“The model that is in my head is that people have different [gut] Environments and microbes are compatible with them or not, “she says.” And there is a window where, if you are microbes, you may be able to stick to but you may not progress. And then the evolution somehow gets you there. You may not be able to fit exactly when you land there, but you are close enough to hang out and get there. While you are completely incompatible in other people with what is already there, and residential microbes have been beaten. “
Her work is just one of the many projects that use new approaches to developing Lieberman, which has been developed in 2018. year collected by cystic fibrosis, genetic diseases that causes the mucus to build in the lungs and creates infection conditions. Patients were among those who developed bacterial infections during the 1990s outbreak.
Lieberman and her colleagues recognized the perfect opportunity to use genetic sequencing technologies to study the way in which gene Burkolderia Dolosa The bacterium has evolved when it built those samples. What was permitted B. To adjust and survive? Many survivors of microbes, discovered, developed similar mutations independently in different patients, suggesting that at least some of these mutations helped to progress. The research showed that genes were worthy of further study – and suggested that this approach promises to understand what needed to grow well in the human body.
Lieberman joined the ALM Laboratory in 2015. year, with the aim of applying the same experimental paradigm and statistical techniques that developed below in the emerging microbiome research. In its ownership laboratory, the approach has developed to understand how natural selection pressures result in mutations that can help certain installation microbes. This includes studying colonies of bacteria that form on human skin.
“The idea is to create a genetically constructed metabolite factory in the intestines.”
Daniel Pascal
In the intestines, Lieberman explains hundreds of different types of microbes coexist and the coevile, forming a heterogeneous community whose members work with each other in ways that are not fully understood. This creates a wide range of confusing variables that make it difficult to identify why some graph and others do not. But on the skin the metabolic environment is less complex, such a small type of bacteria coexist. A smaller number of species makes it far easier to monitor the genome of specific microbes of time to facilitate survival, and the availability of the skin makes it easier to understand how the spatial structure and presence of other microbes affect this process.
One discovery from Lieberman’s laboratory is that each pair is dominated only by one random strain of one species. Its group hypothesizes that survival may depend on the geometry of the microbial pores. For example, because these anaerobic microbes usually succeed in the lower nanos to access the pores, where there is less oxygen, the first to succeed in coming there can lose new migrants.
“My vision, and a really vision for the microbiime field in general,” says Lieberman, whether one-day therapeutic microbes can be added to the treatment of medical conditions. “It could be microbes that naturally occur or could be genetic engineering microbes that have a certain property we want,” she adds. “But how actually do it is really challenging because we don’t understand the ecology of the system.” Most bacteria introduced into a person, even those who were taken from another healthy man, will not be persevered, unless you would be the bombs with antibiotics “why it’s”, it’s adding it, “something we really don’t understand.”
